BHD syndrome is an inherited genetic condition linked to benign skin growths, collapsed lung and kidney cancers. Since it was founded in 2007, the Myrovlytis Trust has concentrated on BHD syndrome. Learn more at Our Work: BHD Research. Since 2011, the Myrovlytis Trust’s work on BHD syndrome is carried out through the BHD Foundation.
Related kidney disorders
Our work promoting research into BHD syndrome has increasingly connected with work on related disorders. Extending our support to related genetic kidney disorders is therefore a logical progression that will enable an increased understanding of these disorders. Recent advances suggest gene therapy may become a viable and attractive option for treating genetic disorders. An effective renal gene therapy option could have potential application in a range of genetic kidney disorders, including BHD syndrome.